Covid-19
Blog

EU MDR Implementation Extension - helps in Compliance Planning

EU MDR Implementation Extension - Helps in Compliance Planning

May 07, 2020 EU MDR

We all aware that the implementation date of Medical Device Regulations (EU) 2017/745 (EU MDR) been extended by one year (26 May 2021) and the amendment was published in the Official Journal of the European Union on 23 April 2020. It’s a positive note and great opportunity for manufacturers to make their products compliance with increased requirements of EU MDR.

Key Points to be understood from the amendment of Regulation (EU) 2017/745:

  • Arrow Applies to MDR only, no change to IVDR (2017/746)
  • Arrow The date '26 May 2020' is replaced by '26 May 2021' in this amendment.
  • Arrow The repeal of the Medical Device Directives (90/385/EEC and 93/42/EEC) is delayed by one year, i.e. repeal by 26 May 2021 (Article 122 Repeal)
  • Arrow EC shall ensure that EUDAMED is fully functional at a date that allows the Commission to publish the notice by 25 March 2021 (Article 34 Functionality of Eudamed)
  • Arrow By way of derogation from Article 9(1) and (2) of Directive 90/385/EEC or from Article 11(1) to (6) of Directive 93/42/EEC, any competent authority may authorize, on a duly justified request till 25 May 2021 and may extended using Implementing Acts (Article 59 Derogations from the conformity assessment procedures)
  • Arrow The Member States shall lay down the rules on penalties applicable for infringement of the provisions of this Regulation and shall notify the Commission of those rules and of those measures by 25 February 2021 (Article 113 Penalties)
  • Arrow There is no extension of MDD Certificates issued in accordance with Directives are valid until 26 May 2024 or end of the period indicated on the certificate, provided that from 26 May 2021. It continues to comply with either of those Directives, and provided there are no significant changes in the design and intended purpose (Article 120 Transitional provisions)
  • Arrow Class I device pursuant to Directive 93/42/EEC, for which the declaration of conformity was drawn up prior to 26 May 2021 where requires the involvement of a notified body as per the conformity assessment procedure pursuant to this Regulation
  • Arrow Devices lawfully placed on the market as of May 26, 2021 may continue to be made available until May 26, 2025.
  • Arrow Notified bodies which are designated and notified in accordance with this Regulation may carry out the conformity assessment procedures laid down in this Regulation and issue certificates in accordance with this Regulation prior to 26 May 2021.
  • Arrow Devices manufactured utilizing derivatives of tissues or cells of human origin (Article 1(6) g) have been legally placed on the market or put into service in accordance with the rules in force in the Member States prior to 26 May 2021 may continue to be placed on the market and put into service in the Member States concerned.
  • Arrow Reusable devices shall bear the UDI carrier on the device itself. Implementation dates for Unique Device Identification (UDI) has been updated (Article 123 Entry into force and date of application) as follows:
    • implantable devices and class III devices - from 26 May 2023
    • class IIA and class IIB devices - from 26 May 2025
    • class I devices - from 26 May 2027

The main key point is that there are no amendments taken place in the regulatory requirements of EU MDR regarding Technical, Clinical, PMS, Quality, Labeling and Regulatory aspects. This extended timeline allows the Manufacturers, Notified Bodies, Authorized Representatives and other Economic Operators for more robust planning and implementation to compliance with EU MDR.

Tags:

EU MDR